Brief: Enveric Biosciences Inc - Receives U.S. Patent For Evm301 Series Of Drug Candidates On March 17
31/03/2026 13:38
March 31 (Reuters) - Enveric Biosciences Inc ENVB.O: ENVERIC BIOSCIENCES INC - RECEIVES U.S. PATENT FOR EVM301 SERIES OF DRUG CANDIDATES ON MARCH 17 Source text: ID:nBwbJgYswa Further company coverage: ENVB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003